Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Radiance Medical Systems (NasdaqNM:RADX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Location
13900 Alton Parkway, Suite 122
Irvine, CA 92618
Phone: (949) 457-9546
Fax: (949) 581-4761
Employees (last reported count): 66
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 23%
·Over the last 6 months:
 · 3 insider buys; 24.0K shares (0.8% of insider shares)
·Institutional: 31% (40% of float)
(36 institutions)
·Net Inst. Selling: 144.0K shares (+3.68%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Radiance Medical Systems, Inc. is developing proprietary devices to deliver radiation to prevent the recurrence of blockages in arteries following balloon angioplasty, vascular stenting and other interventional treatments of blockages in coronary and peripheral arteries. The Company incorporates its proprietary RDX technology into catheter-based systems that deliver beta radiation to the site of a treated blockage in an artery in order to decrease the likelihood of restenosis. The application of beta radiation inside the artery at the site of a blockage has proven clinically effective in inhibiting cell proliferation, a cause of restenosis.
More from Market Guide: Expanded Business Description

Financial Summary
Radiance Medical Systems, Inc. designs, develops, manufactures and markets catheters used to treat certain vascular diseases, which enable physicians to deliver therapeutic radial force, stents, drugs or contrast media to the treatment site. For the six months ended 6/01, sales fell 21% to $3.9 million. Net loss totalled $6.4 million, up from $2.6 million. Revenues reflect increasing competition. Higher loss reflects higher expenditures for US clinical trials.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Michael Henson, 55
Chairman
$437K$17K
Jeffrey Thiel, 45
Pres, CEO, Director
237K--  
Stephen Kroll, 54
CFO, VP of Fin. and Admin., Sec.
230K--  
Paul Molloy, 39
Sr. VP of Sales and Marketing
--  --  
Joseph Bishop, 36
VP-Operations
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:RADXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 2-Apr-2001
$2.438
Recent Price$3.00 
52-Week High
on 11-Sep-2000
$15.00 
Beta0.69 
Daily Volume (3-month avg)29.4K
Daily Volume (10-day avg)18.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-78.2%
52-Week Change
relative to S&P500
-70.7%
Share-Related Items
Market Capitalization$39.2M
Shares Outstanding13.1M
Float10.1M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.22 
Earnings (ttm)-$0.73 
Earnings (mrq)-$0.24 
Sales (ttm)$0.62 
Cash (mrq)$1.36 
Valuation Ratios
Price/Book (mrq)1.35 
Price/EarningsN/A 
Price/Sales (ttm)4.80 
Income Statements
Sales (ttm)$7.89M
EBITDA (ttm)-$10.0M
Income available to common (ttm)-$9.23M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-28.43%
Return on Equity (ttm)-32.47%
Financial Strength
Current Ratio (mrq)5.83 
Debt/Equity (mrq)0 
Total Cash (mrq)$17.8M
Short Interest
As of 8-Aug-2001
Shares Short33.0K
Percent of Float0.3%
Shares Short
(Prior Month)
37.0K
Short Ratio1.00 
Daily Volume33.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.